Jeena Sikho LifecareNSE:JSLL +1.52%87 EV-to-EBIT is 22.53 as of Jul. 08, 2026, which is 53% below its 10-year median of 48.01. GuruFocus rates NSE:JSLL with a GF Score™ of 87/100 and a GF Value™ of ₹776.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks worse than 66.67% on this metric.
The historical rank and industry rank for Jeena Sikho Lifecare's EV-to-EBIT or its related term are showing as below:
NSE:JSLL'
s EV-to-EBIT Range Over the Past 10 Years
Min: 22.07 Med: 48.01 Max: 155.93
Current: 22.53
During the past 8 years, the highest EV-to-EBIT of Jeena Sikho Lifecare was 155.93. The lowest was 22.07. And the median was 48.01.
NSE:JSLL's EV-to-EBIT is ranked worse than 66.67% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.965
vs NSE:JSLL: 22.53
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Jeena Sikho Lifecare's Enterprise Value for the quarter that ended in Mar. 2026 was ₹66,091 Mil.
Jeena Sikho Lifecare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,102 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare EV-to-EBIT Related Terms
Jeena Sikho Lifecare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's EV-to-EBIT falls into.
Jeena Sikho Lifecare's current Enterprise Value is ₹69,906 Mil.
Jeena Sikho Lifecare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,102 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeena Sikho Lifecare (NSE:JSLL) has a EV-to-EBIT of 22.53 as of Jul. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Jeena Sikho Lifecare and its competitors. This is 53% below median its historical median of 48.01. Over the past decade, Jeena Sikho Lifecare's EV-to-EBIT has ranged from 22.07 to 155.93. According to the industry distribution chart, Jeena Sikho Lifecare ranks #312 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 66.7%.
Is Jeena Sikho Lifecare's EV-to-EBIT too high?
Jeena Sikho Lifecare's current EV-to-EBIT of 22.53 is 53% below median its 10-year median of 48.01. Over the past 10 years, this metric has ranged from a low of 22.07 to a high of 155.93. The Healthcare Providers & Services industry median EV-to-EBIT is 15.97. Jeena Sikho Lifecare's value of 22.53 is 41.1% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #312 out of 468 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Jeena Sikho Lifecare has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #312 out of 468 companies for EV-to-EBIT. This places Jeena Sikho Lifecare in the lower half of its industry. The industry median EV-to-EBIT is 15.97. Jeena Sikho Lifecare's value of 22.53 is 41.1% above this benchmark. Historically, Jeena Sikho Lifecare's own EV-to-EBIT has ranged from 22.07 to 155.93 over the past decade. While the company's 10-year median is 48.01 vs. the industry median of 15.97, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.97, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current EV-to-EBIT of 22.53 is 41.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current EV-to-EBIT is 22.53, which is 53% below median its own 10-year median of 48.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹776.38, compared to a current price of ₹570.40 — trading 26.5% below its estimated fair value. The current EV-to-EBIT is 22.53, which is 53% below median its 10-year median of 48.01 and 41.1% above the Healthcare Providers & Services industry median of 15.97. Jeena Sikho Lifecare's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current EV-to-EBIT is 22.53 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹570.40 is trading 26.5% below its estimated GF Value™ of ₹776.38.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
EV-to-EBIT: 22.53 (53% below median its 10-year median of 48.01)
GF Value™: ₹776.38 vs. price of ₹570.40 (26.5% below fair value)
Industry Position: 41.1% above the Healthcare Providers & Services median (#312 of 468)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
87GF Score
Get the complete analysis for NSE:JSLL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
